Skip directly to site content Skip directly to search


Español  Other Languages


An official website of the United States government Here's how you know
 Official icon**Official websites use .gov**
				A .gov website belongs to an official government organization in the United States. Lock icon**Secure .gov websites use HTTPS**
				A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
	CDC LogoCDC Logo
 Search

		×
			NIOSH
			NIOSH

				All CDC
				Submit


The National Institute for Occupational Safety and Health (NIOSH)





Study Syllabus for Classification of Radiographs of Pneumoconioses						Print
																Related Pages
										Clinical OverviewMajor Occupational Lung DiseasesGranulomatous Diseases
Hypersensitivity Pneumonitis
Hypersensitivity pneumonitis (HP), also called extrinsic allergic alveolitis, is caused by inhalation of antigens that trigger a diffuse mononuclear cell inflammation of the small airways and lung parenchyma. The three broad categories of causal antigens are: (1) fungal and microbial agents, (2) animal proteins, and (3) low molecular weight chemicals.
The clinical presentation of HP has been classified as acute, subacute or chronic. The flu-like respiratory illness of acute HP occurs within 4 to 12 hours of exposure, with fever, cough, dyspnea, chills, malaise, chest tightness and myalgias. Physical examination may show fever, tachypnea, tachycardia, and rales. With subacute and chronic HP, patients report insidious onset of dyspnea on exertion, dry or minimally productive cough, fatigue, malaise, anorexia and weight loss. Bibasilar crackles may be detectable on lung auscultation; right heart failure and digital clubbing may be present in advanced cases of fibrosis. Pulmonary function testing shows restriction, obstruction or mixed abnormalities, often with decreased DLCO and/or exercise-induced gas exchange abnormalities.
The chest radiograph (CXR) is often normal in patients with HP, with an estimated sensitivity of only 10% [Hodgson et al. 1989]. In acute HP (Fig. 12), the CXR may show diffuse ground glass or airspace consolidation. Patients with subacute HP may have a combination of nodular or reticulonodular opacities with ground glass. Chronic fibrotic HP usually has a CXR appearance of reticular opacities with honeycombing. Though the HRCT pattern is variable depending on the stage of HP, characteristic findings include centrilobular ground-glass nodular opacities, diffuse ground-glass abnormality, and mosaic attenuation with expiratory air-trapping (Fig. 12, hypersensitivity pneumonitis showing features of ground glass opacity, traction bronchiectasis, and mosaic attenuation, and Fig. 13 showing air trapping at arrows). Such findings may be seen in patients with acute, subacute or chronic disease. The distribution of findings in acute or subacute HP is often diffuse, while the findings of chronic HP may show upper, middle or lower lung predominance [Silva et al. 2008]. Some patients with chronic HP develop lung fibrosis, characterized by reticular abnormality, traction bronchiectasis, and sometimes honeycombing, often in association with centrilobular nodularity, ground glass, or mosaic attenuation. Emphysema (Fig. 14, two different patients) and cystic change (Fig. 15) may also occur in chronic HP, even in never smokers.
Histologic findings vary depending upon the stage of disease. The classic HP triad of histopathologic features is lymphocytic alveolitis; small, loose non-necrotizing granulomas; and cellular bronchiolitis. In chronic HP, variable stages of interstitial fibrosis may be found including a nonspecific interstitial pneumonitis (NSIP) pattern, centrilobular and peribronchiolar fibrosis, bridging fibrosis, and a usual interstitial pneumonia (UIP)-like pattern. Findings of lymphocytic infiltration, giant cells, poorly formed granulomas, and bridging fibrosis can help differentiate HP from other fibrotic lung diseases.ASBESTOSIS AND ASBESTOSPage 5 of 6CHRONIC BERYLLIUM DISEASE
							
					
							Last Reviewed:  April 26, 2023						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeStudy Syllabus for Classification of Radiographs of Pneumoconioses
Introductionplus icon
Preface
Appreciation to Contributors
Intent of the Self-study Syllbus
Getting Started
Clinical Overviewplus icon
Major Occupational Lung Diseasesplus icon
Pneumoconioses
Central Role of Diagnostic Imagingplus icon
Role of CT
Overview of Nonimaging Clinical Tools in Lung Disease Diagnosis
Appendix A
References
Pathology Overviewplus icon
Pulmonary Silicosis
Coal Workers’ Pneumoconiosis
Asbestos Pleuropulmonary Disease
Pathological-Clinical Correlations
References
Radiograph Classificationplus icon
SUBSET 1 – Radiograph Classification, #1 to #19plus icon
Introduction
Radiograph Identification
Section 1: Image Quality
Section 2: Parenchymal Abnormalities, #1 to #14
Section 3: Pleural Abnormalities, #15 to #19
Section 4: Any Other Abnormalities
Section 5
SUBSET 2 – Radiograph #20 to #27plus icon
Radiograph #20
Radiograph #21
Radiograph #22
Radiograph #23
Radiograph #24
Radiographs #25 to #27
SUBSET 3 – Radiograph #28 to #38plus icon
Radiographs #28 to #30
Radiographs #31 to #32
Radiographs #33 to #35
Radiographs #36 to #38
SUBSET 4 – Radiograph #39 to #46 (Small and Large Opacities)plus icon
Radiographs #39 to #40
Radiographs #41 to #42
Radiographs #43 to #44
Radiograph #45
Radiograph #46
SUBSET 5 – Classifications and Answer Keys, Radiographs #47 to #83
Quiz Error processing SSI file  Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue